Evidence map›Paper›PMID 36243840›Full record

ArticleCurrent topics in microbiology and immunology2022

Class III PI3K Biology.

Manuella Caux, Gaetan Chicanne, Sonia Severin

Abstract read
PubMed Publisher
In one paragraph

Article in Current topics in microbiology and immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Manuella CauxInserm U1297 and Paul Sabatier University, Institute of Cardiovascular and Metabolic Diseases, I2MC, 31432, Toulouse, France.
Gaetan ChicanneInserm U1297 and Paul Sabatier University, Institute of Cardiovascular and Metabolic Diseases, I2MC, 31432, Toulouse, France.
Sonia SeverinInserm U1297 and Paul Sabatier University, Institute of Cardiovascular and Metabolic Diseases, I2MC, 31432, Toulouse, France. sonia.severin@inserm.fr.
Institut des Maladies Métaboliques et Cardiovasculaires · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Highly conserved from yeast to mammals, vacuolar protein sorting 34 (Vps34) is the sole member of the third class of the phosphoinositide 3-kinase (PI3K) family. By producing phosphatidylinositol-3-monophosphate (PtdIns3P) through its scaffolding function essential for the catalytic lipid activity, Vps34 regulates endosomal trafficking, autophagy, phagocytosis, and nutrient-sensing signaling. The development of genetically modified mouse models and specific inhibitors has largely contributed over the past ten years to a better understanding of Vps34 functions in biological and physiological processes in mammals and, ultimately, its potential implications and targeting in human diseases. This chapter will summarize the current knowledge of the structure and regulation of Vps34 as well as its cellular and organismal functions.

Indexed as

Phosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesAnimalsAutophagyBiologyEndosomesHumansMammalsMiceSaccharomyces cerevisiaePhosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesAutophagyPhosphatIdylinositol-3-monophosphateSignalingVesicular traffickingVps34

Identifiers

PMID36243840
OpenAlexW4306362027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.